Outreach Messages Up Well-Child Visits, Vaccination Completion

TUESDAY, Nov. 22, 2022 (HealthDay News) -- Outreach messages delivered via electronic health record patient portals increase the rates of scheduling and completing well-child visits and receiving the COVID-19 vaccine, according to a study published online Nov. 18 in JAMA Network Open.
Anne E. Berset, from the Cincinnati Children’s Hospital Medical Center, and colleagues examined the effectiveness of patient portal outreach messages, with and without the date of the last well-child care, on the scheduling and completion of well-child visits and completion of vaccinations within two weeks. The analysis included 945 participants randomly assigned to the standard message, tailored message, or no message (control) groups.
The researchers found that scheduling rates were 18.4 percent in the standard message group (adjusted risk ratio [aRR], 1.97) and 14.9 percent in the tailored message group (aRR, 1.57) versus the control group (9.5 percent). Similarly, well-child care visit completion rates were higher in the standard message group (aRR, 1.92) and tailored message group (aRR, 1.52) versus the control group. Rates of receiving the COVID-19 vaccine among eligible children were 16.7 percent in the standard message group versus 4.8 percent in the tailored message group (aRR, 3.41) and 3.7 percent in the control group (aRR, 4.84).
"Additional efforts are needed to reengage at-risk populations and recover preventive services missed during the pandemic," the authors write.
Related Posts
Long Stays Common for Kids Who Visit ERs in Mental Health Crisis
WEDNESDAY, Dec. 28, 2022 (HealthDay News) -- It's a scenario no parent would...
COVID-19-Related Stress During Pregnancy Tied to Poor Postpartum Outcomes
THURSDAY, March 16, 2023 (HealthDay News) -- Antenatal COVID-19-related stress...
ADA: Once-Weekly Tirzepatide Leads to Weight Loss in Patients With Obesity, T2D
TUESDAY, June 27, 2023 (HealthDay News) -- Once-weekly tirzepatide provides...
Testosterone Therapy for Hypogonadism Not Tied to Increased CV Risk
FRIDAY, June 10, 2022 (HealthDay News) -- For men with hypogonadism,...